| 
																	
																	
																		 Connection
 
																		 Co-Authors
																		
																	 
																		This is a "connection" page, showing publications co-authored by   Joel Marrs   and   Joseph Saseen.    
																		
																	 
																			
																					
					
					
		
			
			
			|  | 
				
					|  | Connection Strength |  |  
					|  |   |  |  
					|  | 1.770 |  |  |  |  
		
		
			
				Marrs JC, Saseen JJ. Effects of lipid-lowering therapy on reduction of cardiovascular events in patients with end-stage renal disease requiring hemodialysis. Pharmacotherapy. 2010 Aug; 30(8):823-9.	
				
				
					Score: 0.347
				
				Marrs JC, Saseen JJ. Dyslipidemia control in indigent patients receiving medication assistance compared with insured patients. Pharmacotherapy. 2008 May; 28(5):562-9.	
				
				
					Score: 0.297
				
				Marrs JC, Saseen JJ. Which patients are candidates for dipeptidyl peptidase IV inhibitors? Am J Health Syst Pharm. 2007 Jun; 64(12):1261.	
				
				
					Score: 0.279
				
				Marrs JC, Orlando ST, Saseen JJ, Novins-Montague S, Sandy LC, Waughtal J, Glorioso TJ, Ho PM. Description of patient questions received by clinical pharmacists in the Nudge Study. Am J Health Syst Pharm. 2023 09 07; 80(18):1247-1254.	
				
				
					Score: 0.215
				
				Nardolillo JA, Marrs JC, Anderson SL, Hanratty R, Saseen JJ. Retrospective cohort study of statin prescribing for primary prevention among people living with HIV. JRSM Cardiovasc Dis. 2021 Jan-Dec; 10:20480040211031068.	
				
				
					Score: 0.186
				
				Kelly MS, Saseen JJ, Marrs JC. Assessment of achieved systolic blood pressure in newly treated hypertensive patients aged 60-79 years before and after Eighth Joint National Committee recommendations. Ther Adv Cardiovasc Dis. 2017 Feb; 11(2):63-71.	
				
				
					Score: 0.136
				
				Zupec JF, Marrs JC, Saseen JJ. Evaluation of Statin Prescribing for Secondary Prevention in Primary Care Following New Guideline Recommendations. Ann Pharmacother. 2016 Jan; 50(1):17-21.	
				
				
					Score: 0.124
				
				Lowe RN, Marrs JC, Saseen JJ. Patterns of serum laboratory monitoring for safety and efficacy in patients on chronic statin therapy. Ther Adv Drug Saf. 2013 Feb; 4(1):9-17.	
				
				
					Score: 0.103
				
				Ho PM, Glorioso TJ, Allen LA, Blankenhorn R, Glasgow RE, Grunwald GK, Khanna A, Magid DJ, Marrs JC, Novins-Montague S, Orlando S, Peterson P, Plomondon ME, Sandy LM, Saseen JJ, Trinkley KE, Vaughn S, Waughtal J, Bull S. Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic Cardiovascular Medications: A Randomized Pragmatic Trial. JAMA. 2025 01 07; 333(1):49-59.	
				
				
					Score: 0.059
				
				Hanselin MR, Saseen JJ, Allen RR, Marrs JC, Nair KV. Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents. Hypertension. 2011 Dec; 58(6):1008-13.	
				
				
					Score: 0.024
				 | 
																	
																		
																			
																					       Connection Strength       
  The connection strength for concepts is the sum of the scores for each matching publication.    
 Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
 |